Advertisement

Topics

DIAGNOSTIC ONCOLOGY CRO, Inc Company Profile

05:07 EST 11th December 2018 | BioPortfolio

DOCRO is the leading clinical research organization specializing in the design and conduct of clinical trials of in vitro diagnostic products to gain marketing clearance/approval from the U.S. Food and Drug Administration. DOCRO has demonstrated its expertise and real-world experience in the development, clinical validation, and market-making introduction of many of then new and innovative, but now standard of care, diagnostic tests in the field of oncology. DOCRO's name is a bit of a misnomer because DOCRO does provide services outside the field of tumor marker assays. DOCRO has a great deal of experience with a wide variety of protein based and molecular biology-based diagnostic tests. Beside our core specialty of oncology, DOCRO has worked extensively in infectious diseases, perinatal and prenatal disease, cardiology, endocrinology, metabolic diseases, obstetrics and gynecology, hematology/coagulation, transplant immunology, drugs of abuse, and other medical specialties

Location

73 Cogwheel Lane
Seymour
Connecticut
06483
United States of America

Contact

Phone: 203.881.1032
Fax: 203.881.1193
Email: info@docro.com


News Articles [781 Associated News Articles listed on BioPortfolio]

Randox exhibit diagnostic innovations at Oncology Congress

Diagnostic firm Randox Laboratories has this week sent a delegation of Scientists from its Biosciences Division to take part in the UK Exhibition of Oncology Excellence, which is taking place 25–29 ...

New diagnostic tool for complex cancer cases

(University of Gothenburg) A new diagnostic tool is expected to result in better treatment of cancer that is difficult to diagnose. The tool was developed by cancer researchers at Sahlgrenska Academy ...

New diagnostic tool for difficult-to-detect cancers

A new diagnostic tool is expected to result in better treatment of cancer that is difficult to diagnose. The tool was developed by cancer researchers at Sahlgrenska Academy and doctors at the Sahlgren...

Ockham Oncology’s CSO highlights global strength of fully integrated company.

Ockham Oncology’s Chief Scientific Officer Clare Wareing, PhD recounts the companies history and emphasizes complementary strengths that add value following the combination of Ockham Oncology and Ne...

Clovis Oncology to Present at the Credit Suisse 27th Annual Healthcare Conference

Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J. Mahaffy, Chief Executive Officer and President, will present at the 27th Annual Healthcare Conference on Wedne...

Analysis of oncology pipeline

Oncology research, which includes the medical, radiation, and surgical fields, is always ongoing. Therefore, the oncology pipeline is a key...Read More... The post Analysis of oncology pipeline appear...

Clovis Oncology to Present at the Morgan Stanley Global Healthcare Conference

Clovis Oncology, Inc. (Nasdaq: CLVS) today announced that Patrick J. Mahaffy, Chief Executive Officer and President, will present at the 16th Annual Morgan Stanley Global Healthca...

Transplant Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends, and ...

LONDON, Oct. 17, 2018 /PRNewswire/ -- Transplant Diagnostic Market - Overview This report on the transplant diagnostic market analyzes the current and future scenario of Read more...

Drugs and Medications [31 Associated Drugs and Medications listed on BioPortfolio]

Neutrexin (trimetrexate glucuronate for injection) [MedImmune Oncology, Inc.]

NEUTREXIN (trimetrexate glucuronate for injection)

Fludeoxyglucose f18 [THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Fludeoxyglucose f 18 [Triad Isotopes, Inc.]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Fludeoxyglucose f 18 [Precision Nuclear LLC]

These highlights do not include all the information needed to use Fludeoxyglucose F18 Injection safely and effectively. See full prescribing information for Fludeoxyglucose F18 Injection. Fludeoxygluc...

Fludeoxyglucose f 18 [PETNET Solutions, Inc.]

These highlights do not include all the information needed to use F ludeoxyglucose   F 18   I njection safely and effectively. See full prescribing information for F ludeoxyglucose   F

PubMed Articles [2313 Associated PubMed Articles listed on BioPortfolio]

Pembrolizumab KEYNOTE-001: an adaptive study leading to accelerated approval for two indications and a companion diagnostic.

Clinicopathological factors influence diagnostic accuracy of clinical N staging for early gastric cancer.

Treatment Outcomes in Patients with Metastatic Neuroendocrine Tumors: a Retrospective Analysis of a Community Oncology Database.

Metastatic neuroendocrine tumors (mNETs) are rare, heterogeneous tumors that present diagnostic and treatment challenges, with limited data on the management of mNETs in clinical practice. The present...

Diagnostic performance of F-choline PET-CT in prostate cancer.

To evaluate the diagnostic performance of F-choline PETCT in staging prostate cancer (PC) and whether the use of this imaging modality changes the therapeutic decision in patients previously staged by...

Breast microcalcifications: biological and diagnostic perspectives.

Clinical Trials [2781 Associated Clinical Trials listed on BioPortfolio]

Diagnostic Imaging of Lymph Nodes in Gynaecologic Oncology

The purpose of the study is to determine the diagnostic accuracy of a new magnetic resonance imaging (MRI) technique, the diffusion weighted imaging with body background signal suppression...

Communicating a Cancer Diagnosis-Current Methods and Their Effects

This study will investigate how patients are informed of their cancer diagnosis or recurrence and will explore their experience in learning about the diagnosis. Specifically, it will: ...

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best che...

Support of the Sexual Health in Oncology

Implementation of sexual health support program in oncology department. This program is organized in 3 axes. One is to inform the side effects of treatment on sexual health. There is a co...

Clinical Concordance Study Between Watson for Oncology and Clinician Practice

At present, Watson for Oncology has been applied in 14 countries worldwide, including China, the United States, Holland, Thailand, India, Korea, Poland, Slovakia and Bangladesh. In a doubl...

Companies [1737 Associated Companies listed on BioPortfolio]

DIAGNOSTIC ONCOLOGY CRO, Inc

DOCRO is the leading clinical research organization specializing in the design and conduct of clinical trials of in vitro diagnostic products to gain marketing clearance/approval from the U.S. Food an...

Clarient, Inc.

Clarient combines innovative diagnostic technologies with world class pathology expertise to assess and characterize cancer. Clarient's mission is to become the leader in cancer diagnostics by dedica...

ChipDX LLC

ChipDX develops and delivers novel multi-gene diagnostic and prognostic assays for oncology research use only. The aim of the company is to increase access to advanced, well-valid...

OTraces, Inc.

OTraces (www.OTraces.net) is a biotech company based in Rockville, Md, that provides advanced oncology diagnostic systems. It has developed a protein-based method (proteomi...

Takeda Oncology

Takeda Oncology, headquartered in Cambridge, MA, delivers novel medicines to patients with cancer worldwide through its commitment to science, breakthrough innovation and passion ...

More Information about "DIAGNOSTIC ONCOLOGY CRO, Inc" on BioPortfolio

We have published hundreds of DIAGNOSTIC ONCOLOGY CRO, Inc news stories on BioPortfolio along with dozens of DIAGNOSTIC ONCOLOGY CRO, Inc Clinical Trials and PubMed Articles about DIAGNOSTIC ONCOLOGY CRO, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DIAGNOSTIC ONCOLOGY CRO, Inc Companies in our database. You can also find out about relevant DIAGNOSTIC ONCOLOGY CRO, Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record